We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
- Authors
Fossella, F V; DeVore, R; Kerr, R N; Crawford, J; Natale, R R; Dunphy, F; Kalman, L; Miller, V; Lee, J S; Moore, M; Gandara, D; Karp, D; Vokes, E; Kris, M; Kim, Y; Gamza, F; Hammershaimb, L
- Abstract
To confirm the promising phase II results of docetaxel monotherapy, this phase III trial was conducted of chemotherapy for patients with advanced non-small-cell lung cancer (NSCLC) who had previously failed platinum-containing chemotherapy.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Vol 18, Issue 12, p2354
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2000.18.12.2354